FGF23 and chronic kidney disease: In contrast, in the NaPi-IIb−/− mouse there was only partial amelioration of hyperphosphatemia in adenine-induced CKD, and additional treatment with sevelamer was required to prevent this and reduce FGF-23 levels [34▪▪].